RBOT
Vicarious Surgical Inc.NYSEHealthcare$0.73+6.67%ClosedMarket Cap: $4.7M
As of 2026-04-04
Valuation
P/E (TTM)
—
PEG
—
P/B
0.54
P/S
0.00
EV/EBITDA
-0.21
DCF Value
$-1.02
FCF Yield
-872.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-247.6%
ROA
-256.3%
ROIC
-289.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-10.2M | $-10.5M | $-1.57 | — |
| FY 2025 | $0.00 | -Infinity% | $-51.0M | $-50.2M | $-8.45 | — |
| Q3 2025 | $0.00 | -Infinity% | $-11.5M | $-11.1M | $-1.86 | — |
| Q2 2025 | $0.00 | NaN% | $-13.5M | $-13.2M | $-2.23 | — |
| Q1 2025 | $0.00 | NaN% | $-15.7M | $-15.4M | $-2.60 | — |
| Q4 2024 | $0.00 | -Infinity% | $-15.0M | $-13.9M | $-2.36 | — |
| FY 2024 | $0.00 | -Infinity% | $-66.6M | $-63.2M | $-10.72 | — |
| Q3 2024 | $0.00 | NaN% | $-17.8M | $-17.1M | $-2.90 | — |
| Q2 2024 | $0.00 | NaN% | $-17.7M | $-15.2M | $-2.59 | — |
| Q1 2024 | $0.00 | NaN% | $-16.1M | $-17.0M | $-3.17 | — |
| Q4 2023 | $0.00 | -Infinity% | $-15.5M | $-13.1M | $-2.25 | — |
| FY 2023 | $0.00 | -Infinity% | $-80.7M | $-71.1M | $-14.60 | — |